BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/12/2024 10:04:16 AM | Browse: 134 | Download: 533
 |
Received |
|
2023-10-05 04:12 |
 |
Peer-Review Started |
|
2023-10-05 04:14 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-12-08 04:16 |
 |
Revised |
|
2023-12-21 08:36 |
 |
Second Decision |
|
2024-01-18 02:54 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-01-18 05:29 |
 |
Articles in Press |
|
2024-01-18 05:29 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-03-04 01:29 |
 |
Publish the Manuscript Online |
|
2024-03-12 10:04 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Case Control Study |
Article Title |
N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Yan-Rong Wen, Xia-Wen Lin, Yu-Wen Zhou, Lei Xu, Jun-Li Zhang, Cui-Ying Chen and Jian He |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Affiliated Drum Tower Hospital, Medical School of Nanjing University |
2021-LCYJ-MS-11 |
|
Corresponding Author |
Jian He, Doctor, PhD, Chief Doctor, Department of Nuclear Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, No. 321 Zhongshan Road, Nanjing 210008, Jiangsu Province, China. hjxueren@126.com |
Key Words |
Glycomics; N-glycans; Biomarkers; Pancreatic cancer; Predictive modeling |
Core Tip |
This study employed a patient cohort to investigate the N-glycan signature of early-stage pancreatic cancer (PC). Serum N-glycans analysis was conducted to identify the serum biomarker signature associated with early-stage pancreatic ductal adenocarcinoma (PDAC), resulting in the identification of nine early-stage PDAC N-glycan signatures. Subsequently, utilizing these biosignatures, a diagnostic model named the “Glyco-model” was developed, demonstrating promising diagnostic performance across all stages of PC. The study revealed that the diagnostic sensitivity for stage I PDAC was determined to be 89.66%. Consequently, this diagnostic model exhibits potential as a prospective strategy for the early detection of PDAC. |
Publish Date |
2024-03-12 10:04 |
Citation |
Wen YR, Lin XW, Zhou YW, Xu L, Zhang JL, Chen CY, He J. N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer. World J Gastrointest Oncol 2024; 16(3): 659-669 |
URL |
https://www.wjgnet.com/1948-5204/full/v16/i3/659.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v16.i3.659 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345